Cresset Asset Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,353
| Closed | -$82.4K | – | 1752 |
|
2025
Q1 | $82.4K | Sell |
10,353
-11,881
| -53% | -$94.6K | ﹤0.01% | 1603 |
|
2024
Q4 | $202K | Sell |
22,234
-83,430
| -79% | -$758K | ﹤0.01% | 1538 |
|
2024
Q3 | $970K | Buy |
105,664
+41,541
| +65% | +$381K | ﹤0.01% | 1152 |
|
2024
Q2 | $627K | Buy |
64,123
+8,219
| +15% | +$80.4K | ﹤0.01% | 1301 |
|
2024
Q1 | $844K | Sell |
55,904
-3,290
| -6% | -$49.7K | ﹤0.01% | 1044 |
|
2023
Q4 | $1.28M | Buy |
59,194
+8,200
| +16% | +$177K | 0.01% | 778 |
|
2023
Q3 | $948K | Sell |
50,994
-9
| -0% | -$167 | ﹤0.01% | 846 |
|
2023
Q2 | $1.29M | Buy |
+51,003
| New | +$1.29M | ﹤0.01% | 693 |
|
2022
Q4 | – | Sell |
-23,751
| Closed | -$602K | – | 876 |
|
2022
Q3 | $602K | Buy |
23,751
+692
| +3% | +$17.5K | 0.01% | 464 |
|
2022
Q2 | $766K | Sell |
23,059
-304
| -1% | -$10.1K | 0.01% | 433 |
|
2022
Q1 | $1.69M | Buy |
23,363
+875
| +4% | +$63.1K | 0.02% | 277 |
|
2021
Q4 | $2.06M | Sell |
22,488
-1,379
| -6% | -$127K | 0.02% | 294 |
|
2021
Q3 | $3.03M | Buy |
23,867
+895
| +4% | +$114K | 0.04% | 163 |
|
2021
Q2 | $3.82M | Buy |
22,972
+5,036
| +28% | +$838K | 0.05% | 137 |
|
2021
Q1 | $3.26M | Buy |
17,936
+11,333
| +172% | +$2.06M | 0.05% | 129 |
|
2020
Q4 | $1.32M | Buy |
6,603
+2,770
| +72% | +$554K | 0.02% | 204 |
|
2020
Q3 | $841K | Buy |
+3,833
| New | +$841K | 0.02% | 256 |
|
2019
Q2 | – | Sell |
-113
| Closed | -$6K | – | 1558 |
|
2019
Q1 | $6K | Buy |
113
+30
| +36% | +$1.59K | ﹤0.01% | 1317 |
|
2018
Q4 | $4K | Buy |
+83
| New | +$4K | ﹤0.01% | 1121 |
|